SUNNYVALE, Calif., Aug. 12, 2013 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, today announced positive data for MANF in the degenerative disease known as Retinitis Pigmentosa ("RP"). The study concluded that Intravitreal injection of recombinant human MANF protein protects both rods and cones from retinal degeneration in an animal model of RP. RP is a degenerative disorder of the eye that affects roughly 100,000 people in the United States, meaning that it qualifies as an orphan disease under FDA guidelines.
RP refers to a group of inherited diseases causing retinal degeneration. The cell-rich retina lines the back inside wall of the eye and is responsible for capturing images from the visual field. People with RP experience a gradual decline in their vision because photoreceptor cells (rods and cones) die. Symptoms include a progressive degeneration of peripheral and night vision as well as the degeneration in color perception and central vision; night blindness is one of the earliest and most frequent symptoms of RP. RP is typically diagnosed in adolescents and young adults. The rate of progression and degree of visual loss varies from person to person. Most people with RP are legally blind by age 40. It is estimated that the market opportunity for Retinitis Pigmentosa exceeds $10B annually.
"The data announced today is tremendously important to our MANF Orphan program," said Gerald E. Commissiong, CEO of Amarantus. "As we continue to move our internal MANF programs forward related to mediating endoplasmic reticulum (ER) stress, we can now expand the MANF therapeutic development franchise into Ophthalmology. By identifying Retinitis Pigmentosa as an indication for MANF, we have identified a potentially reduced timeline to get MANF to commercialization with a very substantial market opportunity."
The abstract presented by Wen et al from the University of Miami's Bascom Palmer Eye Institute at the Association for Research in Vision and Ophthalmology annual conference in 2012:
To examine the neuroprotective effect of MANF on rod photoreceptors, recombinant human MANF (6 ug) was intravitreally injected to the left eyes of transgenic rat S334ter rats (line 3) at PD9, and the right eyes were injected with PBS as controls. Eyes were collected at PD21 and examined by light microscopy.
To examine effect of MANF on cone photoreceptors, MANF (6 ug) was injected intravitreally to the left eyes of the transgenic rats at PD20, and the right eyes were injected with PBS as controls. Retinas were collected at PD30 and cone outer segments were stained with Alexa 488 conjugated peanut agglutinin (PNA). Flat-mounted retinas were examined by confocal microscopy.
"The identification of an orphan indication for MANF is a key milestone towards the initial commercialization for MANF," said Dr. Joseph Rubinfeld, Amgen co-founder and current member of the Company's Board of Advisors. "The delivery of MANF directly to the eye in this indication will be local, potentially significantly reducing timelines to get this into the marketplace versus systemic applications. We are continuing to look at MANF in other orphan indications and expect to have data in other areas in the coming weeks."
About Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF)
MANF (Mesencephalic-Astrocyte-derived Neurotrophic Factor) is a protein that corrects protein misfolding, one of the major causes of apoptosis (Programmed Cell Death). Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF) is believed to have broad potential because it is a naturally-occurring protein produced by the body for the purpose of reducing and preventing apoptosis (in response to injury or disease), via the unfolded protein response. By manufacturing MANF and administering it to the body, Amarantus is seeking to use a regenerative medicine approach to assist the body with higher quantities of MANF when needed. Amarantus is the front-runner and primary holder of intellectual property (IP) around MANF, and is initially focusing on the development of MANF-based protein therapeutics. MANF's current lead indication is Parkinson's disease with additional focus on Traumatic Brain Injury (TBI). Future indications may include myocardial infarction and certain rare and ultra-rare orphan diseases where MANF is currently being evaluated.
About Amarantus
Continue reading here:
Amarantus Announces Positive Orphan Data for MANF in Retinitis Pigmentosa
- Amarantus BioScience - “Ophthalmology: MANF’s Orphan Strategy Coming into Focus in Retinitis Pigmentosa” - August 14th, 2013 [August 14th, 2013]
- RiverDogs Donate $20,000 to MUSC Storm Eye Institute - August 14th, 2013 [August 14th, 2013]
- Casino mogul Steve Wynn donates $25 million to find cure for eye disease he has - August 14th, 2013 [August 14th, 2013]
- Explaining Retinitis Pigmentosa, RP - Video - August 14th, 2013 [August 14th, 2013]
- FIRATLI CLINIC ISTANBUL Retinitis Pigmentosa HeilungTunnelBlick) - Video - August 18th, 2013 [August 18th, 2013]
- Treatment for retinitis pigmentosa - Video - August 18th, 2013 [August 18th, 2013]
- FIRATLI CLINIC ISTANBUL Retinitis Pigmentosa Treatment DUTCH) - Video - August 20th, 2013 [August 20th, 2013]
- FIRATLI CLINIC AvtarEngland) A MUST WATCH FOR Retinitis Pigmentosa Treatment (+Visionfieldtest) - Video - August 20th, 2013 [August 20th, 2013]
- Argus® II Retinal Prosthesis System Gets Government Funding in Both USA and Europe - August 21st, 2013 [August 21st, 2013]
- Second Sight Medical Named 2014 Technology Pioneer - September 1st, 2013 [September 1st, 2013]
- Retinitis pigmentosa treated with acupuncture - Video - September 1st, 2013 [September 1st, 2013]
- Man Copes with Retinitis Pigmentosa - September 8th, 2013 [September 8th, 2013]
- Dompé Announces the Food and Drugs Administration (FDA) Has Granted Orphan Drug Designation to its rhNGF-based ... - September 11th, 2013 [September 11th, 2013]
- September is healthy aging month—keep your mind active with free talking books - September 12th, 2013 [September 12th, 2013]
- Visually-impaired educator helps guide New Caney students - September 13th, 2013 [September 13th, 2013]
- Bionic eye shines light on darkness - September 15th, 2013 [September 15th, 2013]
- Football fan’s quest helps him to savor his fading sight - September 15th, 2013 [September 15th, 2013]
- Whole DNA sequencing reveals mutations, new gene for blinding disease - September 16th, 2013 [September 16th, 2013]
- This Week in PNAS - September 17th, 2013 [September 17th, 2013]
- First Self-Powered Artificial Retina Could Allow Normal Visual Acuity and Restoration of Color Vision - September 17th, 2013 [September 17th, 2013]
- Bionic eye offers gift of sight - September 24th, 2013 [September 24th, 2013]
- Lesa Kretschmer, CEO of Florida Reading & Vision Technology Inc., Named Honorary Chair of the 2013 South Florida ... - September 26th, 2013 [September 26th, 2013]
- Blind Yuba City man: ‘I walk every day, rain or shine’ - September 30th, 2013 [September 30th, 2013]
- Sun Pharma ties up with US company to offer new treatment of ocular diseases - October 1st, 2013 [October 1st, 2013]
- Sun Pharma and Intrexon Form Joint Venture to Develop New Class of Therapeutics for Ocular Diseases - October 1st, 2013 [October 1st, 2013]
- Sun Pharma inks joint venture with Intrexon - October 2nd, 2013 [October 2nd, 2013]
- NIH Scientists Pursue New Therapies To Improve Rare Disease Drug Development - October 2nd, 2013 [October 2nd, 2013]
- New bionic eye may help restore some vision in blind - October 8th, 2013 [October 8th, 2013]
- Trio heading to B.C. to join finish of Craig Gives Back tour - October 8th, 2013 [October 8th, 2013]
- Simple urine test could help diagnose eye disease - October 9th, 2013 [October 9th, 2013]
- The Low Vision Exam: Low Vision Specialists of Maryland and Virginia #3: - Video - October 10th, 2013 [October 10th, 2013]
- Blind cyclist nearing Penticton - October 10th, 2013 [October 10th, 2013]
- Retinitis Pigmentosa: Almost normal vision after 12 months treatment - Video - October 10th, 2013 [October 10th, 2013]
- Kelly: Steve Lonegan's passion fueled by challenges - October 13th, 2013 [October 13th, 2013]
- Glasses for Macular Degeneration: Low Vision Specialists of Maryland and Virginia #5 - Video - October 13th, 2013 [October 13th, 2013]
- Simple blood or urine test to identify blinding disease - October 16th, 2013 [October 16th, 2013]
- Blind Florida running back reaches the end zone during game - October 18th, 2013 [October 18th, 2013]
- Retinal Prosthesis System: 2014 Medical Innovation No. 1 - Video - October 20th, 2013 [October 20th, 2013]
- RetroSense Therapeutics Selected by Windhover as a “Top Project to Watch: Most Licensable Product” - October 28th, 2013 [October 28th, 2013]
- Retinitis Pigmentosa Treatment - October 31st, 2013 [October 31st, 2013]
- Retinitis pigmentosa - Genetics Home Reference - October 31st, 2013 [October 31st, 2013]
- Retinitis Pigmentosa Symptoms, Signs, Treatment, Causes, Research ... - October 31st, 2013 [October 31st, 2013]
- Foundation Fighting Blindness - What is Retinitis Pigmentosa? - October 31st, 2013 [October 31st, 2013]
- Retinitis pigmentosa - RNIB - RNIB - supporting blind and ... - October 31st, 2013 [October 31st, 2013]
- Retinitis pigmentosa: MedlinePlus Medical Encyclopedia - November 9th, 2013 [November 9th, 2013]
- Retinitis pigmentosa - National Library of Medicine - PubMed Health - November 11th, 2013 [November 11th, 2013]
- Retinitis Pigmentosa 11-06-2013 - Video - November 13th, 2013 [November 13th, 2013]
- Retinitis Pigmentosa treatment - acunova eye acupuncture after John Boel - Video - November 14th, 2013 [November 14th, 2013]
- Retinitis pigmentosa - Wikipedia, the free encyclopedia - November 21st, 2013 [November 21st, 2013]
- Retinitis pigmentosa | University of Maryland Medical Center - November 21st, 2013 [November 21st, 2013]
- Retinitis Pigmentosa - Low Vision - November 23rd, 2013 [November 23rd, 2013]
- Retinitis Pigmentosa or RP - AllAboutVision.com - November 26th, 2013 [November 26th, 2013]
- Retinitis Pigmentosa - Video - December 9th, 2013 [December 9th, 2013]
- RP International Spreads Holiday Cheer with The Eyes of Christmas™ - December 12th, 2013 [December 12th, 2013]
- UT Dallas Materials Scientist Research Contributes to Invention Recognized by Time Magazine - December 19th, 2013 [December 19th, 2013]
- Time is short, and sight is precious, for Sydney family living under shadow of mystery disease - December 19th, 2013 [December 19th, 2013]
- Me Driving (Prt 2) - Video - December 23rd, 2013 [December 23rd, 2013]
- Treatment of Retinitis Pigmentosa: normal vision after 9 months - Video - December 28th, 2013 [December 28th, 2013]
- Seeing Tomorrow - Video - January 1st, 2014 [January 1st, 2014]
- Edible batteries to power pacemakers + more - January 2nd, 2014 [January 2nd, 2014]
- How to cure blindness, concussions and baldness - January 2nd, 2014 [January 2nd, 2014]
- Matthew unlocks the iPad for blind and partially-sighted - January 4th, 2014 [January 4th, 2014]
- How poor eyesight led to a great vision - January 5th, 2014 [January 5th, 2014]
- Tea Thyme in Texas fundraiser set to be held at The Overlook - January 10th, 2014 [January 10th, 2014]
- Ballard author has hope that heals - January 11th, 2014 [January 11th, 2014]
- Distance runner knows the joy of competition - January 14th, 2014 [January 14th, 2014]
- Gene Therapy Tested as a Way to Stop Blindness - January 16th, 2014 [January 16th, 2014]
- Treatment may save thousands from blindness - January 16th, 2014 [January 16th, 2014]
- Gene therapy gives sight back to patients due to go blind - January 16th, 2014 [January 16th, 2014]
- Gene Therapy May Restore Sight in People With Rare Blinding Disease - January 16th, 2014 [January 16th, 2014]
- Blind Civil Rights Attorney, Athlete To Speak At Chabad House - January 17th, 2014 [January 17th, 2014]
- Visual Field Test results 4- Medical Evidence of Retinitis Pigmentosa Treatment- FIRATLI CLINIC - Video - January 20th, 2014 [January 20th, 2014]
- Gesichtsfeldtests 2- Retinitis Pigmentosa Behandlung (Retinopathia Pigmentosa) - FIRATLI KLINIK - Video - January 20th, 2014 [January 20th, 2014]
- Visual Field Test results 3-Medical Evidence of Retinitis Pigmentosa Treatment- FIRATLI CLINIC - Video - January 21st, 2014 [January 21st, 2014]
- Visual Field Test Results 2- Retinitis Pigmentosa Treatment- FIRATLI CLINIC - Video - January 21st, 2014 [January 21st, 2014]
- Visual field test results 1-Medical Evidence of Retinitis Pigmentosa Treatment- FIRATLI CLINIC - Video - January 21st, 2014 [January 21st, 2014]
- Mass. Eye and Ear physician awarded RPB Career Development Award - January 23rd, 2014 [January 23rd, 2014]
- Retinitis Pigmentosa Treatment / Behandlung- FIRATLI CLINIC Proof( Visual Field Test) Eng subtitle! - Video - January 23rd, 2014 [January 23rd, 2014]
- Retinitis Pigmentosa Treatment / Behandlung- FIRATLI CLINIC German with Eng.Subtitles - Video - January 23rd, 2014 [January 23rd, 2014]
- Visual Field Results 2-Medical Proof of Retinitis Pigmentosa Treatment- FIRATLI CLINIC - Video - January 27th, 2014 [January 27th, 2014]